CVS Health: Buy the Vertical-Integration Re-Rate as Cash Flow and Scale Align
CVS is a vertically integrated healthcare operator trading below historical peaks with solid free cash flow, a healthy dividend, and multiple operational catalysts. A patient, long-term trade with a defined entry at $93.015, stop at $83, and target of $115 aims to capture a re-rating and continued margin recovery.